Basics Vivos Therapeutics, Inc. IPO Date: July 7, 2020 Sector: Healthcare Industry: Medical Devices Market Cap: $30.92M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 5.14% Avg Daily Range (30 D): $0.25 | 5.58% Avg Daily Range (90 D): $0.20 | 4.91% Institutional Daily Volume Avg Daily Volume: .87M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .43M Trade Size Avg Trade Size (Sh.): 237 Avg Trade Size (Sh.) (30 D): 169 Avg Trade Size (Sh.) (90 D): 118 Institutional Trades Total Inst.Trades: 24 Avg Inst. Trade: $.98M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $.84M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.05M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $.84M Avg Closing Volume: 12.46K     News Aug 20, 2025 @ 8:24 PM Vivos Reports 7% Sales Drop Source: Jesterai Jun 27, 2024 @ 11:30 AM Vivos Therapeutics Announces Positive Results From... Source: Vivos Therapeutics, Inc Jun 12, 2024 @ 11:30 AM Vivos Therapeutics Closes $7.5 Million At-The-Mark... Source: Vivos Therapeutics, Inc May 14, 2024 @ 11:30 AM Vivos Therapeutics Schedules Release of First Quar... Source: Vivos Therapeutics, Inc Apr 9, 2024 @ 11:30 AM Vivos Therapeutics’ Flagship CARE Oral Medi... Source: Vivos Therapeutics, Inc Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.16 $-.55 $-.45 Diluted EPS $-1.16 $-.55 $-.45 Revenue $ 14.39M $ 3.82M $ 3.02M Gross Profit $ 8.05M $ 2.11M $ 1.51M Net Income / Loss $ -14.32M $ -5.01M $ -3.86M Operating Income / Loss $ -14.23M $ -4.87M $ -3.92M Cost of Revenue $ 6.35M $ 1.71M $ 1.51M Net Cash Flow $ -2.5M $ -1.86M $ M PE Ratio     Splits Oct 27, 2023:   1:25